# A Study of Human Rhinovirus Type 16 (HRV-16) Following Administration in the Nose of Healthy Adult Volunteers

> **NCT01466738** · PHASE1 · COMPLETED · sponsor: **Centocor Ortho Biotech Services, L.L.C.** · enrollment: 52 (actual)

## Conditions studied

- Healthy

## Interventions

- **BIOLOGICAL:** HRV-16 (100 TCID50)
- **BIOLOGICAL:** HRV-16 (1000 TCID50)

## Key facts

- **NCT ID:** NCT01466738
- **Lead sponsor:** Centocor Ortho Biotech Services, L.L.C.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-09
- **Primary completion:** 2011-11
- **Final completion:** 2011-11
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2012-02-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01466738

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01466738, "A Study of Human Rhinovirus Type 16 (HRV-16) Following Administration in the Nose of Healthy Adult Volunteers". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01466738. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*